IDEAYA BIOSCIENCES INC (IDYA) Stock Income Statement
NASDAQ:IDYA - US45166A1025 - Common Stock
24.93 USD
+0.22 (+0.89%)
25.07 USD
+0.14 (+0.56%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.00M | 7.00M | 23.39M | 50.93M | 27.94M | |||
| Operating Expenses | 391.42M | 333.98M | 157.81M | 113.43M | 78.21M | |||
| Research and Development | N/A | 294.67M | 129.51M | 89.54M | 58.16M | |||
| Selling, General, and Administrative Expenses | 49.20M | 39.30M | 28.31M | 23.90M | 20.05M | |||
| Operating Income | -384.42M | -326.98M | -134.43M | -62.50M | -50.27M | |||
| Interest Income/Expense | N/A | 52.50M | 21.47M | 3.85M | 510.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -331.31M | -274.48M | -112.96M | -58.66M | -49.76M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -331.31M | -274.48M | -112.96M | -58.66M | -49.76M | |||
| EBITDA | -381.95M | -324.59M | -131.95M | -60.40M | -48.54M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.79 | -3.36 | -1.96 | -1.42 | -1.41 | |||
| Non GAAP EPS | -3.79 | -3.30 | -1.97 | -1.39 | -1.39 | |||
| Statistics | ||||||||
| Profit Margin | -4733.01% | -3921.10% | -483.05% | -115.18% | -178.10% | |||
| Operating Profit Margin | -5491.71% | -4671.07% | -574.85% | -122.72% | -179.92% | |||
All data in USD